Drug
Cyclophosphamide
Cyclophosphamide: highest development phase Approved, developed by Bristol-Myers Squibb, Iovance Biotherapeutics, Sandoz and others. 5 trial records tracked on RxWires.
- Highest phase
- Approved
- Developer
- Bristol-Myers Squibb, Iovance Biotherapeutics, Sandoz
Trials
| Drug | Phase | Indication |
|---|---|---|
| CYCLOPHOSPHAMIDE | Approved | |
| Cyclophosphamide NCT03161379 | Phase 2 | Pancreatic Cancer |
| Cyclophosphamide NCT03935347 | Phase 2 | Metastatic Bladder Urothelial Carcinoma |
| Cyclophosphamide NCT05176470 | Phase 1 | Locally Advanced Melanoma |
| cyclophosphamide NCT02650648 | Phase 1 | Neuroblastoma |
Latest
No recent events.
Follow Cyclophosphamide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.